Rationale and design of RETAIN study: Rosuvastatin Effect on Telomere-telomerase system in Acute coronary syndrome patients undergoing percutaneous coronary Intervention

Int J Cardiol. 2015 Apr 1:184:388-390. doi: 10.1016/j.ijcard.2015.02.032. Epub 2015 Feb 24.
No abstract available

Keywords: Percutaneous coronary intervention; Rationale; Rosuvastatin; Telomerase; Telomere.

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / genetics
  • Adult
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention
  • Prospective Studies
  • Rosuvastatin Calcium / pharmacology
  • Rosuvastatin Calcium / therapeutic use*
  • Telomerase / physiology*
  • Telomere Homeostasis / drug effects
  • Telomere Homeostasis / physiology*
  • Treatment Outcome
  • Young Adult

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Rosuvastatin Calcium
  • Telomerase